Friday, December 05, 2025 | 10:31 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

M&M up 12% after it rejects plan to infuse fresh equity in South Korean-arm

The company's board has turned down a proposal to pump in fresh equity of $406 million in its ailing South Korean subsidiary SsangYong Motor Co amid coronavirus crisis

M&M gains 12% after rejects plans to infuse fresh equity In SsangYong
premium

The board has, however, authorised the M&M management to consider a special one-time infusion of up to $32 million over the next three months

SI Reporter Mumbai
Shares of Mahindra & Mahindra (M&M) jumped 12 per cent at Rs 316 on the BSE on Tuesday after the company’s board turned down a proposal to pump in fresh equity of $406 million in its ailing South Korean subsidiary SsangYong Motor Co (SYMC) amid the ongoing Covid-19 crisis.

“Given the current and projected cash flows, the M&M Board took a decision that the company will not be able to inject any fresh equity into SYMC and has urged SYMC to find alternate sources of funding,” the company said in a regulatory filing on Friday after market hours. The Indian auto